Which of the following skin conditions is characterized by red bumps that can form moist, weeping blisters and skin that becomes scaly, raw, or thickened?

A. Isotretinoin does not typically alter potassium levels. Routine monitoring of potassium is not indicated in healthy adolescents taking isotretinoin, as the medication does not have known effects on renal potassium handling or cause electrolyte imbalances in this context. Monitoring potassium is only relevant if the patient has other conditions or medications that affect electrolytes.

B. Isotretinoin can cause hyperlipidemia, increasing cholesterol and triglyceride levels, which may raise the risk for pancreatitis or long-term cardiovascular issues. Baseline lipid panels are obtained before starting therapy, with periodic monitoring during treatment to detect and manage elevations promptly.

C. Isotretinoin is not nephrotoxic, meaning it does not typically impair kidney function. Routine monitoring of BUN and creatinine is not necessary unless the adolescent has preexisting kidney disease or other risk factors. Focus should remain on labs directly affected by the medication.

D. Isotretinoin has no significant impact on serum sodium levels. Hyponatremia is not a known complication of isotretinoin therapy, so routine sodium monitoring is unnecessary in otherwise healthy clients. Laboratory monitoring should prioritize liver function tests and lipid profiles, which are more likely to be affected.

A. Growth hormone (GH) deficiency does not cause early closure of the epiphyseal plates. Instead, GH deficiency results in delayed epiphyseal closure due to slowed skeletal growth.

B. Children with untreated GH deficiency may develop features of premature aging, including decreased muscle mass, increased fat distribution, and reduced energy levels as they grow older. This results from long-term metabolic effects of inadequate GH.

C. GH deficiency often occurs along with other pituitary hormone deficiencies. This can result in delayed puberty, delayed sexual maturation, and lack of secondary sexual characteristics.

D. Short stature is the most prominent complication of untreated GH deficiency. Children grow at a reduced rate and fall below the expected growth curve without GH supplementation.

E. GH deficiency leads to delayed (not advanced) bone age due to impaired skeletal maturation. Radiographs usually show younger-than-expected bone development for the child’s chronological age.